
Pfizer
OrganizationHeard in 147 episodes across 67 shows since Oct 2025
Pfizer Inc. is an American multinational pharmaceutical and biotechnology company headquartered in New York City. Founded in 1849, it researches, develops, manufactures, and commercializes medicines and vaccines across multiple therapeutic areas.
Episodes
This week
Expert statements
Share of the conversation
Mentions of Pfizer per 1,000 mentions of anything, 7-day rolling, across the podcasts PodLume Trends follows.
Show the data
| Day | Share (7-day) | Mentions |
|---|---|---|
| Oct 12 | 0.07‰ | 2 |
| Oct 13 | 0.09‰ | 2 |
| Oct 14 | 0.11‰ | 3 |
| Oct 16 | 0.09‰ | 1 |
| Oct 17 | 0.10‰ | 1 |
| Oct 18 | 0.10‰ | 2 |
| Oct 20 | 0.07‰ | 1 |
| Oct 21 | 0.06‰ | 2 |
| Oct 22 | 0.07‰ | 2 |
| Oct 23 | 0.07‰ | 1 |
| Oct 25 | 0.07‰ | 2 |
| Oct 26 | 0.08‰ | 2 |
| Oct 29 | 0.05‰ | 1 |
| Oct 30 | 0.05‰ | 1 |
| Oct 31 | 0.07‰ | 2 |
| Nov 1 | 0.06‰ | 1 |
| Nov 2 | 0.05‰ | 1 |
| Nov 3 | 0.09‰ | 5 |
| Nov 4 | 0.12‰ | 4 |
| Nov 5 | 0.12‰ | 1 |
| Nov 6 | 0.13‰ | 2 |
| Nov 7 | 0.12‰ | 1 |
| Nov 9 | 0.11‰ | 1 |
| Nov 12 | 0.05‰ | 2 |
| Nov 13 | 0.04‰ | 1 |
| Nov 15 | 0.04‰ | 1 |
| Nov 16 | 0.06‰ | 4 |
| Nov 17 | 0.07‰ | 1 |
| Nov 18 | 0.08‰ | 1 |
| Nov 20 | 0.10‰ | 5 |
Email alert
Email me when Pfizer comes up on a podcast
One email a week at most, with the new episodes that mention Pfizer. Free, no account needed, unsubscribe in one click.
What experts have said about Pfizer
29 statements · 18 positive · 9 negative · 1 mixed · 1 neutral
Pfizer is a preferred investment idea.
“he likes Pfizer is my final trade”
Open the episode · Cracks In The AI Trade… And AMD Reports Results 11/3/26Listen at 42:51
Pfizer’s post-pandemic recovery may be accelerating
“Pfizer's post-pandemic comeback may be gaining steam.”
Open the episode · Midterm Ads Fuel Fox Corp & Pricey Memory Pressures Apple’s CoreListen at 20:29
Pfizer new and acquired product revenue rose over 30% year over year
“Revenue from newly launched and acquired products jumped by more than 30% from a year ago.”
Open the episode · Midterm Ads Fuel Fox Corp & Pricey Memory Pressures Apple’s CoreListen at 20:46
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Episodes
147 episodes featuring Pfizer, newest first
- Nov 20, 2026
Nvidia sell-off exposes wider cracks in the AI tradeCNBC's "Fast Money"Nov 20, 2026 - Nov 20, 2026
Biotech weighs AI disruption against a stronger 2027 deal cycleBiotech HangoutNov 20, 2026 - Nov 20, 2026
AI selloff tests the durability of the investment boomBloomberg SurveillanceNov 20, 2026 - Nov 20, 2026
FDA leadership falters as China biotech reshapes drug competitionThe Readout LoudNov 20, 2026 - Nov 20, 2026
Damodaran weighs AI’s winners against market-wide riskProf G MarketsNov 20, 2026 - Nov 18, 2026
AI’s infrastructure boom collides with human agencyTBPNNov 18, 2026